Venture financing holds steady for device makers

So far, so average. In the first half of 2022 private medical device companies raised $4.4bn in venture funding, putting the year’s total on course to fall neatly between what was raised in the past two years.

The picture is very different when it comes to the other main means of raising cash available to private groups: IPOs. Only three medtechs have braved the falling markets, and the biggest such deal, the spinout of Bausch & Lomb, priced at a heavy discount.